Amorcyte - Ownership and Business Overview

Life ScienceCompany

Amorcyte Ownership

Who owns Amorcyte?

Amorcyte is owned by Caladrius Biosciences. It was acquired on June 15, 2011.

Amorcyte Business Overview

Where is Amorcyte headquartered?

Amorcyte is headquartered in Allendale, New Jersey.

What sector is Amorcyte in?

Amorcyte is a life science company.

When was Amorcyte founded?

Amorcyte was founded in 2005.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

Amorcyte LLC

4 Pearl Court, Suite C,
Allendale, New Jersey 07401
United States,

Amorcyte LLC develops cell therapy products to treat cardiovascular disease.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.